Digital Maturity Assessment: Where Your QMS Stands

The Question Most Quality Managers Can't Answer

Ask a quality manager whether their QMS is "digital," and almost everyone says yes. Ask them a harder question, though, and the confidence drops fast. Suppose an FDA investigator asked for every open CAPA, its age, and its root cause trend, right now. Without anyone opening a spreadsheet or calling someone in another department, how long would that take?

For most organizations I've looked at, the honest answer is somewhere between twenty minutes and never. That gap between "we have software" and "we have a system that actually knows itself" is what I mean by digital maturity. It isn't a yes-or-no question. It's a spectrum, and most companies are stuck in the middle of it without quite realizing they're stuck.

In my view, the reason this matters isn't compliance theater. It's that maturity level predicts what breaks first when the company grows, when an auditor shows up unannounced, or when the one person who understands how the system actually works gives notice. A system's maturity is really a statement about how much of its knowledge lives in software versus how much lives in someone's head.

Five Stages of Quality System Maturity

I think about quality system maturity in five stages. Almost no organization sits neatly in one stage across every process. You'll usually find CAPA further along than training records, or document control ahead of supplier quality. That unevenness is itself diagnostic information.

Most regulated small and mid-size manufacturers I've studied sit at Stage 2, occasionally reaching into Stage 3 for one or two processes. Stage 2 is the trap. It looks like progress because the paper is gone, but the underlying problem, information that doesn't talk to itself, is unchanged. You've digitized the filing cabinet without digitizing the system.

What Actually Signals Maturity

Software licenses don't determine maturity. What determines it is whether a record, once created, can answer questions nobody asked when it was written. A mature system can tell you, without a special report or a favor from IT, which suppliers are trending toward nonconformance, which SOPs haven't been reviewed in the interval your own procedure requires, and which training gaps exist on the floor right now.

ISO 9001:2015 clause 9.1.3 requires an organization to analyze and evaluate data and information arising from monitoring and measurement. Plenty of companies satisfy the letter of that clause with a quarterly spreadsheet pulled together by someone working late. Fewer satisfy the spirit of it, where the analysis is continuous because the underlying data was structured to be analyzed from the moment it was captured.

Document control is the clearest tell. ISO 9001:2015 clause 7.5.3 requires that documented information be controlled to ensure it's available and suitable for use, and protected from loss of confidentiality or improper use. A Stage 2 organization technically controls its documents. It just does so through a combination of naming conventions, tribal memory, and hope. A Stage 4 organization can show you, instantly, that the SOP on the floor right now is the approved current revision, and can prove nobody printed an outdated copy six months ago and forgot about it. I wrote more about what that gap actually costs in the real cost of paper-based quality systems, and it's larger than most people budget for, mostly because the cost hides inside labor nobody labels as "quality overhead."

Why the FDA Started Asking the Same Question

This isn't just my framework. FDA's Center for Drug Evaluation and Research has been building toward the same idea for years under a program called Quality Management Maturity, or QMM. The agency launched voluntary QMM pilot programs for finished dosage form and active pharmaceutical ingredient manufacturers in October 2020. It followed in September 2023 with a Federal Register notice establishing a public docket and requesting comment on a formal QMM rating program for drug manufacturers at both domestic and international sites.

The premise behind QMM is worth sitting with: the FDA is trying to move beyond a binary pass/fail inspection model toward rating how mature a manufacturer's quality culture and systems actually are, on the theory that maturity, not just current compliance, predicts future drug shortages and quality failures. That's a meaningful shift. It says the agency has stopped asking only "are you compliant today" and started asking "will you still be compliant when nobody's watching, and can your system tell the difference between a real problem and noise."

If a federal regulator with enormous inspection resources still finds it worth building a formal maturity model instead of a simple checklist, that should tell every quality manager reading this something about how seriously to take the question for their own operation.

How to Assess Your Own System

You don't need a formal audit to get an honest read on where you stand. A handful of concrete questions will locate you on the five-stage model faster than any consultant's questionnaire.

1. Can you produce a live CAPA aging report right now, with no manual compilation? If the answer involves opening three files and cross-referencing dates by hand, you're at Stage 2 or 3, regardless of what your CAPA software claims to do.
2. When an SOP changes, does the training assignment update itself? In a mature system, revising a document automatically flags everyone whose role requires retraining. In an immature one, someone has to remember to check, and eventually someone forgets. I've written separately about how AI-driven training record management catches these competency gaps before they surface in an audit finding rather than after.
3. Do your quality metrics update in real time, or do they update when someone builds the slide deck? A monthly management review built from a fresh data pull each time isn't a metrics system. It's a research project that happens to recur monthly. I've laid out what a genuinely live quality dashboard looks like in practice, and the difference from a monthly deck is bigger than it sounds until you've lived both ways.
4. If your most experienced quality person left tomorrow, would the system still know what they knew? This is, in my view, the single best maturity test there is, because it separates systems that store information from systems that merely store the fact that information exists somewhere.
5. Can a new record be created without retyping information that already exists elsewhere in the system? Stage 2 systems make people re-enter the same batch number, supplier name, and part number across five different forms. Stage 4 systems pull that information forward automatically, because the record isn't a form, it's a node connected to everything else that already knows those facts.

None of these questions requires special tooling to answer honestly. They just require someone willing to test the system rather than describe it.

The Honest Middle Stage Is the Most Dangerous

Here's the uncomfortable part. Stage 1, pure paper, is at least honest about its limitations. Everyone who works with a paper system knows it's slow and knows records can go missing, so they build in redundancy and caution. Stage 2 is more dangerous precisely because it feels solved. The company bought software, the binders are gone, and leadership tells itself the quality problem has been handled.

But a folder of PDFs is not meaningfully different from a filing cabinet. It's just a filing cabinet that's harder to search and easier to lose track of, because at least a physical binder has one location. I think this is the stage where most quality failures actually get seeded, not in the paper era and not in the mature digital era, but in the false confidence of the middle.

Getting out of Stage 2 doesn't require an enterprise system built for companies ten times your size. It requires connecting the pieces you already have, so that a record created in one place is usable everywhere else without anyone retyping it. That's a smaller, more achievable project than most quality managers assume, and I've written about the actual path from paper to something that meets FDA's expectations for a paperless system without the enterprise price tag.

Where a company sits on the maturity model is not a fixed trait. It is a reflection of decisions made under time pressure, decisions that can be revisited once someone actually names the stage the company is in. Naming it honestly is most of the work. The rest is sequencing.

Frequently Asked Questions

What is digital maturity in a quality management system? Digital maturity describes how connected, analyzable, and self-updating an organization's quality records are, not simply whether the records exist in electronic form. A company can have zero paper and still sit at low maturity if its digital records are siloed and require manual compilation to answer basic questions.

What is FDA's Quality Management Maturity (QMM) program? QMM is a CDER initiative that began with voluntary pilot programs in October 2020, testing how to rate pharmaceutical manufacturing sites on the maturity of their quality systems and culture rather than only their point-in-time compliance status. The agency followed in September 2023 with a Federal Register notice establishing a public docket to gather comment on a formal rating program.

How do I know if my quality system is stuck at a low maturity stage? The clearest signal is whether producing a report, a CAPA trend, a training gap list, an SOP revision history, requires manual compilation from multiple sources. If someone has to gather and cross-reference data by hand, the underlying records aren't structured for analysis, regardless of what software stores them.

Does 21 CFR Part 11 apply to every stage of the maturity model? Part 11 governs electronic records and electronic signatures for FDA-regulated industries once an organization moves off paper, but compliance with Part 11's technical controls, like audit trails and access controls, does not by itself guarantee a mature system. A company can be Part 11 compliant and still sit at Stage 2, siloed and manual, if its compliant records don't connect to each other.

Is a higher maturity stage always worth the investment? Not universally, and the honest answer depends on scale and risk. A very small operation with a handful of SKUs may function adequately at Stage 3. But any organization managing multiple product lines, multiple sites, or frequent regulatory interaction accumulates hidden labor cost at lower maturity stages that usually exceeds the cost of closing the gap.

Last updated: 2026-09-11